| Stage | MMED | % of rev | LMRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $843M | 100.00% | $264M | 100.00% | MMED ×3.19 |
| Gross profit | $465M | 55.16% | $264M | 100.00% | LMRI +44.8pp |
| Operating income | $5M | 0.59% | $4M | 1.67% | LMRI +1.1pp |
| Pre-tax income | $4M | 0.47% | $6M | 2.18% | LMRI +1.7pp |
| Net income | $0 | 0.00% | $3M | 1.04% | LMRI +1.0pp |
| Stage | MMED | LMRI | Gap · A − B |
|---|---|---|---|
| Revenue | $843M100.00% | $264M100.00% | MMED ×3.19 |
| Gross profit | 55.16%$465M | 100.00%$264M | LMRI +44.8pp |
| Operating income | 0.59%$5M | 1.67%$4M | LMRI +1.1pp |
| Pre-tax income | 0.47%$4M | 2.18%$6M | LMRI +1.7pp |
| Net income |
| 0.00%$0 |
| 1.04%$3M |
| LMRI +1.0pp |